Neuroprotection for Parkinson’s disease: a new approach for a new millennium

Author： Drukarch Benjamin   van Muiswinkel Freek L  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.10, 2001-10, pp. : 1855-1868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. : 5558-5573

Bentham Science Publishers

Access to resources Recommend Favorite

New Agents Promote Neuroprotection in Parkinson's Disease Models

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 4, 2012-06 ,pp. : 410-418

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4936-4947

Bentham Science Publishers

Access to resources Recommend Favorite

Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson’s Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 4, 2016-02 ,pp. : 346-359

Bentham Science Publishers

Access to resources Recommend Favorite

New directions in Parkinson’s research and treatment

By Napolitano A.   Pezzella A.   Misuraca G.   Prota G.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 10, 1998-10 ,pp. : 1251-1268

Informa Healthcare

Access to resources Recommend Favorite